Transforming Diagnosis (article by Thomas Insel, Director of the NIMH): “In a few weeks, the American Psychiatric Association will release its new edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)…While DSM has been described as a “Bible” for the field, it is, at best, a dictionary, creating Read the rest of this entry »
By: Alvaro Fernandez
Time for SharpBrains’ February 2012 eNewsletter, featuring in this occasion multiple and complementary perspectives on how to harness neuroplasticity: with enthusiasm, BOTH physical AND cognitive exercise, and (once tools become better standardized and widely available) brain-based personalized medicine.
- The State of Personalized Medicine: The Role of Biomarkers
- Personalized Medicine in Psychiatry: from DSM to brain-based RDoC, iSPOT-D and biomarkers
- Working with Healthcare Stakeholders towards Brain-Based Personalized Medicine
What’s New and Meaningful:
Finally, let us mention that Brain Awareness Week is approaching (March 12-18th, 2012), and that you can now add comments to SharpBrains articles via Facebook (see below). Looking forward to a great month of March!
By: Dr. Evian Gordon
(Editor’s Note: this is Part 2 of the new 3-part series written by Dr. Evian Gordon drawing from his participation at the Personalized Medicine World Congress on January, 23, 2012 at Stanford University.)
Most Personalized Medicine research in Psychiatry using molecular measures alone have failed to replicate. Whilst disappointing, this is not surprising, since 80% of human 25,000 genes have some effect on the brain.
There are therefore growing efforts expanding Genomic Biomarkers in Psychiatry to Neuroimaging (all Brain-based biological and cognitive measures). Some approaches target Read the rest of this entry »